Cocaine Dependence

3
Pipeline Programs
2
Companies
3
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
3
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

2 companies ranked by most advanced pipeline stage

Catalyst Pharmaceuticals
Catalyst PharmaceuticalsCORAL GABLES, FL
2 programs
2
VigabatrinPhase 21 trial
vigabatrinPhase 21 trial
Active Trials
NCT00527683CompletedEst. Nov 2007
NCT00611130CompletedEst. Oct 2012
Alkermes
AlkermesDUBLIN 4, Ireland
1 program
1
VIVITROLPhase 21 trial
Active Trials
NCT00777062CompletedEst. Sep 2013

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
AlkermesVIVITROL
Catalyst Pharmaceuticalsvigabatrin
Catalyst PharmaceuticalsVigabatrin

Clinical Trials (3)

NCT00777062AlkermesVIVITROL

VIVITROL as a Treatment for Cocaine and Alcohol Dependence

Start: Jul 2009Est. completion: Sep 2013
Phase 2Completed
NCT00611130Catalyst Pharmaceuticalsvigabatrin

Vigabatrin for Treatment of Cocaine Dependence

Start: Jan 2008Est. completion: Oct 2012
Phase 2Completed
NCT00527683Catalyst PharmaceuticalsVigabatrin

Double Blind Study of Vigabatrin for the Treatment of Cocaine Dependence

Start: Apr 2007Est. completion: Nov 2007
Phase 2Completed

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

2 companies competing in this space